Cetuximab Recruiting Phase 1 Trials for Squamous Cell Carcinoma (SCC) / Carcinoma, Squamous Cell of Head and Neck Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02438995Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck